Rabbits in Colorado are sprouting "horns." Here's why.
The cottontails recently spotted in Fort Collins are infected with the mostly harmless Shope papillomavirus, which causes wart-like growths that protrude from their faces like metastasizing horns.
Viral photos have inspired a fluffle of unflattering nicknames, including "Frankenstein bunnies," "demon rabbits" and "zombie rabbits." But their affliction is nothing new, with the virus inspiring ancient folklore and fueling scientific research nearly 100 years ago.
The virus likely influenced the centuries-old jackalope myth in North America, which told of a rabbit with antlers or horns, among other animal variations. The disease in rabbits also contributed to scientists' knowledge about the connection between viruses and cancer, such as the human papillomavirus that causes cervical cancer.
The virus in rabbits was named after Dr. Richard E Shope, a professor at The Rockefeller University who discovered the disease in cottontails in the 1930s.
News about the rabbit sightings in Fort Collins, 65 miles north of Denver, started getting attention after residents started spotting them around town and posting pictures.
"It looks like it was black quills or black toothpicks sticking out all around his or her mouth," Susan Mansfield, a Fort Collins resident who saw one of the rabbits, told 9News. "I thought he would die off during the winter, but he didn't. He came back a second year, and it grew."
Kara Van Hoose, a spokesperson for Colorado Parks and Wildlife, told The Associated Press on Wednesday that the agency has been getting calls about the rabbits seen in Fort Collins.
But she said that it's not uncommon to see infected rabbits, especially in the summer, when the fleas and ticks that spread the virus are most active. The virus can spread from rabbit to rabbit but not to other species, including humans and pets, she said.
Rabbit papilloma is similar to human HPV-induced tumors, according to an article in the National Library of Medicine, and human papillomavirus has been linked to skin cancer, according to a recent report.
The growths resemble warts but can look like horns if they grow longer, Van Hoose said. The growths don't harm rabbits unless they grow on their eyes or mouths and interfere with eating. Rabbits' immune systems are able to fight the virus and, once they do, the growths will disappear, she said.
The agency notes that the disease is more severe in domestic rabbits than in wild rabbits and should be treated by a veterinarian.
Colorado is home to three different species of cottontail rabbits -- the mountain cottontail, the desert cottontail and the eastern cottontail. The species differ mostly by color and are "difficult or impossible to distinguish in the field, except by habitat and geographic location," Colorado Parks and Wildlife says.
Tropical Storm Erin expected to become a major hurricane
Trump claims "land swapping" between Russia, Ukraine will happen
Sneak peek: Unmasking the Zombie Hunter
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Bausch + Lomb board members resign after Icahn agreement ends
(Reuters) -Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group's net long position in Bausch Health Companies, Bausch + Lomb's parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital, along with certain affiliates and managed funds, increased their position in the company and acquired about 34.7 million common shares previously held by the Icahn Group. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health's shares. Sign in to access your portfolio

Yahoo
3 minutes ago
- Yahoo
Vulcan Elements signs rare earths supply deal with ReElement Technologies
(Reuters) -Vulcan Elements, a North Carolina-based rare earth magnet manufacturer, has agreed to buy a supply of the critical minerals from ReElement Technologies that will be sourced outside of China. The companies, both of which are privately held, declined to give precise financial terms but said that the price is "significantly below" the floor of $110 per kilogram that the U.S. Department of Defense guaranteed to MP Materials last month for the two most popular rare earths. The contract was signed in mid-July, Vulcan said. Rare earth oxides are used to make metal that can then be turned into magnets for use in fighter jets, radar and other military applications, as well as consumer electronics. "This pricing will enable Vulcan to be competitive in global markets," Vulcan CEO John Maslin told Reuters. "We wanted to make sure the unit economics made sense." Indiana-based ReElement, which licenses its technology from Purdue University, will supply Vulcan with "thousands of metric tons" of rare earth oxides annually for five years beginning in 2026 from outdated electronics or from mine sites, said CEO Mark Jensen. ReElement says it can supply the rare earths to Vulcan below $110 per kilogram because of its use of a processing technique known as chromatography, which is different than the industry-standard solvent extraction used by many of its peers. "We are laser focused on cost," Jensen told Reuters. "We will see where the market goes, but right now we're focused more on the market price versus that price floor." Reuters was first to report last month that the Trump administration is considering extending that price floor to other firms, news that was relayed in a close-door Washington meeting attended by Vulcan, ReElement and others.


Geek Wire
5 minutes ago
- Geek Wire
Seattle health-tech startup Kevala acquired by Residex in bid to enhance senior care with AI
GeekWire's startup coverage documents the Pacific Northwest entrepreneurial scene. Sign up for our weekly startup newsletter , and check out the GeekWire funding tracker and venture capital directory . Todd Owens, CEO of Seattle-based health-tech startup Kevala. (Gavin Haag Photo) Seattle-based Kevala, a startup that helps healthcare facilities find and manage workers, has been acquired by Residex, a Denver company that also uses AI to manage records and more for senior living communities. Terms of the deal were not shared in a news release on Monday. Kevala was spun out of Seattle's Pioneer Square Labs in 2020. The company raisied $4 million in January 2021 and another $12.1 million in February 2022. Co-founder and CEO Todd Owens previously led staffing company TalentWise, which was acquired by Sterling Talent Solutions; was CEO at Appuri (acquired by DocuSign); and was CEO at Azuqua (acquired by Okta). According to Residex, the acquisition will strengthen the company's position in the senior care technology market by adding staffing optimization to platform. Residex uses AI to help manage resident health records, medication administration, care planning, assessments, and clinical documentation. Kevala's software, called Quin, enables healthcare facilities to schedule workers, organize the labor pool and track caregiver credentials. 'This acquisition validates our vision of using AI to solve the industry's most pressing operational challenge of ensuring topline workforce management,' Owens said in a statement. By combining Quin's workforce intelligence with Residex's clinical expertise, we're creating a powerful ecosystem that ultimately enhances the quality of life for residents.' As of April of this year, Kevala employed 28 people and had raised $21 million. Related: